Integrating theories of the etiology of Crohn's Disease on the etiology of Crohn's Disease: Questioning the hypotheses

Medical Science Monitor

Volumn 12, Issue 2, 2006, Pages

  Chamberlin, William M ^a   Naser, Saleh A ^b  

^a Texas Tech Medical Center   (United States)

^b UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Crohn's disease; Etiology; Mycobacteria

Indexed keywords

BACTERIAL ANTIGEN; PROTEIN; PROTEIN P 36; PROTEIN P35; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ANTIGENICITY; AUTOIMMUNITY; BACTERIUM CULTURE; BLOOD CULTURE; COLON FLORA; CROHN DISEASE; HUMAN; HYPOTHESIS; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOSTIMULATION; IN SITU HYBRIDIZATION; INNATE IMMUNITY; INTESTINE; INTESTINE FLORA; MILK; MYCOBACTERIUM AVIUM; MYCOBACTERIUM PARATUBERCULOSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVIEW; SURVIVAL; THEORY VALIDATION; THEORY-PRACTICE RELATIONSHIP; TISSUE CULTURE;

ANIMALS; AUTOIMMUNITY; CROHN DISEASE; HUMANS; IMMUNE TOLERANCE; IMMUNITY, NATURAL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MODELS, BIOLOGICAL; MODELS, IMMUNOLOGICAL; MUTATION; MYCOBACTERIUM PARATUBERCULOSIS; NOD2 SIGNALING ADAPTOR PROTEIN;

EID: 32044443174     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Gastroenterology - Special issue; 2004, vol. 126, number 6
2. Podalsky DK: Inflammatory bowel disease. N Eng J Med, 2002; 347: 417-29
3. Bouma G, Strober W: The immunological and genetic basis of inflammatory bowel disease. Nature Review: Immunology, 2003; 3: 521-33
4. Lim W, Hanauer S: Emerging biologic therapies in inflammatory bowel disease. Reviews in Gastroenterological Disorders, 2004; 4: 66-85
5. Ogura Y, Bonen DK, Inohara N et al: A frame shift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature, 2001; 411: 603-6
6. Hugot JP, Chamaillard M, Zouali H et al: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature, 2001; 411: 599-603
7. Kelsall B: Getting to the Guts of NOD2. Nature Medicine, 2005; 11(4): 383-84
8. Ferwerda G, Girardin S, Kullberg B: NOD2 and Toll-Like Receptors are Nonredundant Recognition Systems of Mycobacterium tuberculosis. PLOS Pathogens. 2005; Vol. 1: issue3: e34, (may be viewed online)
9. Geijtenbeek T, Van Vliet SJ, Koppel EA et al: Mycobacteria target DC-SIGN to suppress Dendritic cell function. J Exper Medicine, 2003; 197(1): 7-17
10. Sechi L, Gazouli M, Ikonomopoulos J et al: Mycobacterium avium subsp. Paratuberculosis, Genetic Susceptibility to Crohn's Disease, and Sardinians: the Way Ahead. Journal of Clinical Microbiology, 2005; 5275-77
11. Karakousis PC, BishaiWR, Dorman SE: Mycobacterium tuberculosis cell envelope lipids and the host immune response. Cellular Microbiology, 2004; 6(2), 105-16
12. Nagabhushanam V, Solache A, Ernst J et al: Innate inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits macrophage responses to IFN-gamma. J of Immunology, 2003; 171: 4750-57
13. Chiodini RJ: Crohn's disease and the mycobacterioses: a review and comparison of two disease entities. Clin Microbiol Rev, 1989; 2: 90-117
14. Chiodini RJ, Van Kruiningen HJ, Thayer WR, Coutu JA: Spheroplastic phase of mycobacteria isolated from patients with Crohn's disease. J Clin Microbiol, 1986; 27: 357-63
15. McFadden JJ, Butcher PD, Chiodini R, Hermon-Taylor J: Crohn's disease-isolated mycobacteria are identical to M. para, as determined by DNA probes that distinguish between mycobacterial species. J Clin Microbiol, 1987; 25: 796-801
16. Markesich DC, Graham DY, Yoshimura HH: Progress in culture and subculture of spheroplasts and fastidious acid bacilli isolated from intestinal tissues. J Clin Microbiol, 1988; 26: 1600-3
17. Haagsma J, Mulder CJJ, Eger A et al: M. para isolated from patients with Crohn's disease in The Netherlands. Scand J Gastroenterol, 1989; 24: S158-68
18. Gitnick G, Collins J, Beaman B et al: Preliminary report on isolation of mycobacteria from patients with Crohn's disease. Dig Dis Sci, 1989; 34: 925-32
19. Moss M, Sanderson J, Tizard M et al: PCR detection of M. paratuberculosis and M. avium subsp. silvaticum from long term cultures of Crohn's disease and control tissues. Gut, 1992; 33: 1209-13
20. ChamberlinW, Graham DY, El-Zaatari F et al: Review article: Mycobacterium avium subsp paratuberculosis as one cause of Crohn's disease. Alim Pharmocol Ther, 2001; 337-46
21. Greenstein RJ: Is Crohn's Disease caused by a mycobacterium: Comparisons with leprosy, tuberculosis and Johne's Disease. The Lancet Infectious Diseases, 2003; 3: 507-14
22. Dalziel TK: Chronic interstitial enteritis. Br Med J, 1913; 2: 1068-70
23. Crohn BB, Ginzburg K, Oppenheimer GD: Regional ileitis: a pathological and clinical entity. J Am Med Assoc, 1932; 99: 1323-28
24. Moss M, Sanderson J, Tizard M et al: PCR detection of M. paratuberculosis and M. avium subsp. silvaticum from long term cultures of Crohn's disease and control tissues. Gut, 1992; 33: 1209-13
25. Dell'Isola B, Poyart C, Goulet O et al: Detection of M. paratuberculosis by polymerase chain reaction in children with Crohn's disease. J Infect Dis, 1994; 169: 449-51
26. Lisby G, Andersen J, Engbaek K, Binder V: Mycobacterium paratuberculosis in intestinal tissue from patients with Crohn's disease demonstrated by a nested primer polymerase chain reaction. Scand J Gastroenterol, 1994; 29: 923-29
27. Bull TJ, McMinn EJ, Sidi-Boumedine K et al: Detection and verification of Mycobacterium avium ssp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease. J Clin Microbiol, 2003; 41: 2915-23
28. Autschbach F, Eisold S, Hinz U et al: High Prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn's disease. Gut, 2005; 54: 944-49
29. Ryan P, Bennett MW, Aarons S, Shanahan F: PCR detection of Mycobacterium paratuberculosis in Crohn's disease granulomas isolated by laser capture microdissection. Gut, 2002; 51: 665-70
30. Mishina D, Katsel P, Brown ST et al: On the etiology of Crohn's Disease. Proc Natl Acad Sci USA, 1996; 93: 9816-20
31. Naser S, Shafran I, El-Zaatari FAK: Mycobacterium avium subsp paratuberculosis in Crohn's disease is serologically positive. Clin Diag Lab Immunol, 1999; 6: 282
32. Hulten K, El-Zimaity HMT, El-Zaatari FAK et al: Association between Mycobacterium paratuberculosis and granulomatous Crohn's disease by in situ hybridization. ASM, 199; 640: U-31
33. Sechi LA, Mura M, Tanda F et al: Identification of Mycobacterium avium subsp paratuberculosis in biopsy specimens from patients with Crohn's disease identified by in situ hybridization. J Clin Microbiology, 2001; 39: 4514-17
34. Schwartz D, Shafran I, Romero C et al: Use of short-term culture for identification of Mycobacterium avium subsp. paratuberculosis in tissue from Crohn's disease patients. Clin Microbiol Infect, 2000; 6: 303-7
35. Naser S: Isolation of Mycobacterium avium subsp paratuberculosis from breast milk of Crohn's disease patients. American Journal of Gastroenterology, 2000; 95(4): 1094-95
36. Naser S, Ghobrial G, Romero C, Valentine J: Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's Disease. The Lancet, 2004; 364: 1039-44
37. Sartour RB: Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology, 2004; 126: 1620-33
38. Tessema MZ, Koets AP, Rutten V, Gruys E: How does Mycobacterium avium subsp. paratuberculosis resist intracellular degradation? The Veterinary Quarterly, 2001; 23(4): 153-62
39. Korzenik JR, Dieckgraefe BK: Is Crohn's Disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's Disease. Dig Dis and Sciences, 2000; 45(6): 1121-29
40. Ryan P, Kelly R, Lee G et al: Bacterial DNA within Granulomas of Patients with Crohn's Disease- Detection by Laser Capture Microdissection and PCR. Am J Gastroenterol, 2004; 99: 1539-43
41. Korzenik JR, Dieckgraefe BK, Valentine JF et al. and the Leukine in Crohn's disease study group. Sagramostim (Granulocyte-macrophage colony stimulating factor) for active Crohn's disease. New England Journal of Medicine, 2005; 352(21): 31-39
42. Behr M, Semret M, Poon A, Schurr E: Crohn's Disease, Mycobacteria and NOD2. The Lancet Inf Dis, 2004; 4: 136-37